Astra USA, Inc., et al.; Withdrawal of Approval of 62 Abbreviated New Drug Applications

Özet

The Food and Drug Administration (FDA) is withdrawing approval of 62 abbreviated new drug applications (ANDA's). The holders of the ANDA's notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn. EFFECTIVE DATE: June 22, 1994. FOR FURTHER INFORMATION CONTACT: Lola E. Batson, Center for Drug Evaluation and Research (HFD-360), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-594-1038.